BusinessWorld reports the FDA cleared a daily pill version of Novo Nordisk's Wegovy for weight loss.
Recap by typeshit. Full story at BusinessWorld Online.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
A 170,000-parameter model trained on plant signalling peptide precursors helps put a value on domain-specific pretraining versus simply scaling up.
The analysis notes the women-only result is post hoc and that women also lose more on tirzepatide, framing Novo's move as a play for OB-GYN prescribers.
Loading…